Vera Nilsén, Julia Bojstedt, Johan E. A. Nordström
2026.1.22Frontiers in Transplantation
tlooto Summary
SPK transplantation may be feasible in carefully selected patients with MELAS, ESRD, and diabetes, providing durable renal and metabolic graft function at 5 years, the first reported SPK case in MELAS, with extended follow-up.
Abstract
Background Mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes (MELAS) is a rare mitochondrial DNA disorder that, in severe cases, can result in insulin-dependent diabetes and end-stage renal disease (ESRD). While organ transplantation is a potential treatment, documented cases remain scarce. Methods A 40-year-old patient with dialysis-dependent ESRD and diabetes secondary to MELAS underwent simultaneous pancreas-kidney transplantation. The perioperative and postoperative periods were uncomplicated with only targeted MELAS-specific adaptations to standard protocols. Results During the 5-year follow-up, the patient maintained excellent kidney allograft function and sustained insulin independence, with no need for dialysis or exogenous insulin therapy. At 5 years, creatinine was 77 µmol/L with an estimated GFR above 90 mL/min/1.73 m2, and glycated hemoglobin was 40 mmol/mol. Conclusions SPK transplantation may be feasible in carefully selected patients with MELAS, ESRD, and diabetes, providing durable renal and metabolic graft function at 5 years. To our knowledge, this is the first reported SPK case in MELAS, with extended follow-up.
Citation format
NILSÉN, Vera; BOJSTEDT, Julia; NORDSTRÖM, Johan E. A. Case report: Simultaneous pancreas–kidney transplantation in MELAS: First reported case with 5-year follow-up. Frontiers in Transplantation, 2026, 5: 1737352.